Clinical trial number NCT04341389 for "A Phase II Clinical Trial to Evaluate the Recombinant Novel Coronavirus Vaccine (Adenovirus Vector)" at ClinicalTrials.gov
Clinical trial number NCT04324606 for "A Study of a Candidate COVID-19 Vaccine (COV001)" at ClinicalTrials.gov
Clinical trial number NCT04283461 for "Safety and Immunogenicity Study of 2019-nCoV Vaccine (mRNA-1273) for Prophylaxis SARS CoV-2 Infection" at ClinicalTrials.gov
Clinical trial number NCT04299724 for "Safety and Immunity of Covid-19 aAPC Vaccine" at ClinicalTrials.gov
Clinical trial number NCT04276896 for "Immunity and Safety of Covid-19 Synthetic Minigene Vaccine" at ClinicalTrials.gov
Clinical trial number NCT04336410 for "Safety, Tolerability and Immunogenicity of INO-4800 for COVID-19 in Healthy Volunteers" at ClinicalTrials.gov
dw.com
Clinical trial number [1] for "Paul Ehrlich Institutuak Alemanian SARS-CoV-2ren aurkako txertoaren lehenbiziko entsegua onartu zuen. Probak apiril honetan hasiko dira, BioNTech ekoizleak dioenez"